We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $4.41B
1-Year Est. Return 26.21%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
10 Year Est. Return
AUM
$3.14B
AUM Growth
-$31.5M
Cap. Flow
-$227M
Cap. Flow %
-7.22%
Top 10 Hldgs %
28.63%
Holding
958
New
27
Increased
147
Reduced
630
Closed
110

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.15M
2
IBP icon
Installed Building Products
IBP
+$4.8M
3
ORCL icon
Oracle
ORCL
+$3.39M
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$2.94M
5
AON icon
Aon
AON
+$2.91M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Financials 14.13%
3 Healthcare 9.11%
4 Communication Services 8.46%
5 Consumer Discretionary 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
51
Bank of New York Mellon
BNY
$107B
$11.8M 0.38%
108,580
-9,848
-8% -$1M
MDY icon
52
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$11.3M 0.36%
18,969
-906
-5% -$532K
NVS icon
53
Novartis
NVS
$297B
$11.3M 0.36%
87,975
+927
+1% +$113K
SNY icon
54
Sanofi
SNY
$104B
$10.8M 0.34%
229,277
-6,245
-3% -$301K
MET icon
55
MetLife
MET
$62.1B
$10.8M 0.34%
130,604
-10,542
-7% -$830K
CVX icon
56
Chevron
CVX
$366B
$10.6M 0.34%
68,509
+3,611
+6% +$559K
VWO icon
57
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$10.5M 0.33%
193,023
-4,697
-2% -$242K
VXUS icon
58
Vanguard Total International Stock ETF
VXUS
$163B
$10.4M 0.33%
141,791
+9,923
+8% +$704K
INTU icon
59
Intuit
INTU
$89B
$10.3M 0.33%
15,114
-349
-2% -$252K
CVS icon
60
CVS Health
CVS
$122B
$10.2M 0.33%
135,316
+14,208
+12% +$974K
JNJ icon
61
Johnson & Johnson
JNJ
$625B
$10.1M 0.32%
54,520
-1,616
-3% -$277K
GILD icon
62
Gilead Sciences
GILD
$165B
$9.8M 0.31%
88,278
-1,460
-2% -$166K
PLTR icon
63
Palantir
PLTR
$413B
$9.63M 0.31%
52,780
+6,308
+14% +$1.02M
ABBV icon
64
AbbVie
ABBV
$435B
$9.58M 0.31%
41,354
+6,354
+18% +$1.29M
FISV
65
Fiserv Inc
FISV
$27.9B
$9.5M 0.3%
73,672
-6,130
-8% -$878K
GSK icon
66
GSK
GSK
$106B
$9.48M 0.3%
219,553
-3,866
-2% -$151K
PG icon
67
Procter & Gamble
PG
$339B
$9.22M 0.29%
60,023
-569
-0.9% -$88.9K
CRWD icon
68
CrowdStrike
CRWD
$218B
$9.02M 0.29%
73,556
-1,804
-2% -$205K
FDX icon
69
FedEx
FDX
$75.4B
$8.92M 0.28%
37,831
-4,815
-11% -$1.11M
IJR icon
70
iShares Core S&P Small-Cap ETF
IJR
$112B
$8.86M 0.28%
74,583
-1,721
-2% -$198K
BX icon
71
Blackstone
BX
$110B
$8.79M 0.28%
51,435
-1,737
-3% -$298K
IAU icon
72
iShares Gold Trust
IAU
$64.4B
$8.78M 0.28%
120,599
+3,603
+3% +$235K
BLK icon
73
Blackrock
BLK
$176B
$8.7M 0.28%
7,461
-283
-4% -$316K
XOM icon
74
ExxonMobil
XOM
$634B
$8.65M 0.28%
76,678
+523
+0.7% +$58.1K
PRI icon
75
Primerica
PRI
$9.89B
$8.55M 0.27%
30,818
-2,629
-8% -$706K

Similar funds

Callan Family Office's Q3 2025 Portfolio in Review

As of Q3 2025, Callan Family Office held 958 positions worth $3.14B, down 0.99% from $3.17B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Callan Family Office withdrew a net $227M in Q3 2025, closing 110 positions and reducing 630 holdings. Its most notable exit was Dimensional California Municipal Bond ETF, an estimated $4.27M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Callan Family Office opened a new position in Installed Building Products worth $4.98M.

  • Callan Family Office's largest Q3 2025 buy was Installed Building Products: 20,207 shares worth $4.98M.
  • Callan Family Office added most to Apple in Q3 2025, an estimated $5.15M increase.
  • Callan Family Office's biggest Q3 2025 reduction was Invesco QQQ Trust, cutting an estimated $23.9M.
  • Callan Family Office fully exited Dimensional California Municipal Bond ETF in Q3 2025, selling an estimated $4.27M.
  • Callan Family Office's ten largest holdings make up 29% of its $3.14B portfolio in Q3 2025.
  • Callan Family Office opened 27 new positions and closed 110 in Q3 2025.
  • Callan Family Office's portfolio value fell 0.99% quarter-over-quarter to $3.14B.

Based on Callan Family Office's 13F filing for Q3 2025, filed 4 Nov 2025.